Acción AXDX ACCELERATE DIAGNOSTICS, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Accelerate Diagnostics, Inc.

Acciones

AXDX

US00430H2013

Mercado cerrado - Nasdaq
Otros sitios de cotización
 22:30:00 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
0,9301 USD -1,61 % Gráfico intradía de Accelerate Diagnostics, Inc. +8,28 % -76,27 %
29/03 Accelerate Diagnostics, Inc. informa de los resultados de las ganancias para el año completo finalizado el 31 de diciembre de 2023 CI
28/03 Transcript : Accelerate Diagnostics, Inc., Q4 2023 Earnings Call, Mar 28, 2024

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Certain Warrants of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Certain Restricted Stock Units of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Certain Common Stock of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Certain Stock Options of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Accelerate Diagnostics : Announces 510(k) Submission of the Accelerate Arc™ System to the FDA
Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
Accelerate Diagnostics, Inc. announced that it expects to receive $4.749996 million in funding from Jack W. Schuler Living Trust
Top Midday Decliners
Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
Sector Update: Health Care Stocks Weaker Late Afternoon
Sector Update: Health Care
Top Midday Decliners
Accelerate Diagnostics Announces Launch of Proposed Public Offering
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
Accelerate Diagnostics, Inc. Announces Preliminary Unaudited Revenue Results for the Year Ended December 31, 2023
Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination with Bruker's MALDI Biotyper
Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination With Bruker´s MALDI Biotyper
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción AXDX
  4. Noticias Accelerate Diagnostics, Inc.
  5. Otros idiomas